Tissue Retractors for Radiation Therapy of Head and Neck Tumors

STATUS

Recruiting
participants needed

34
sponsor

University Hospital Heidelberg

Send

Updated on 19 February 2024

See if I qualify

head and neck cancer

dental caries

neck tumor

head and neck neoplasms

tumour resection

Summary

Show definitions

The rate of therapy-associated side effects during and after radiotherapy of head and neck tumors is essential. The most effective approach to reducing acute toxicity is to cut out healthy tissue from the radiation field. The distance between the tumor and normal tissue can be individually increased using personalized, 3D printer-based tissue retractors (GWR). Even the smallest geometric changes lead to a significant dose reduction in normal tissue and significant advantages for the patient.

The current randomized phase II study evaluates the use of GWR with regard to acute toxicity. In addition, quality of life, long-term toxicity as well as local control and overall survival 12 months after radiotherapy are evaluated.

Description

The most effective approach to reducing acute toxicity after radiotherapy is to cut out healthy tissue from the radiation field. GWR can increase the distance between the tumor and normal tissue. Even the smallest geometric changes lead to a significant dose reduction in normal tissue and significant advantages for the patient. Adequate immobilization also reduces unwanted movements, especially of the tongue.

The GWR are manufactured as combinable modules according to the "modular principle". This improves reproducibility and flexibility and reduces development and manufacturing costs. The study is being conducted as a monocentric, prospective, randomized phase II study. A total of 34 patients who meet the inclusion criteria are examined for acute toxicity after radiotherapy of a malignant head and neck tumor. The primary goal of the study is to reduce acute toxicity through individual immobilization of the jaw and tongue. Secondary study goals are the evaluation of quality of life and long-term toxicity as well as local control and overall survival twelve months after radiotherapy. In both groups, radiation therapy is carried out in accordance with guidelines using image-guided radiotherapy.

Details

Condition	head and neck cancer, head and neck cancer
Age	18years - 99years
Treatment	tissue retractors
Clinical Study Identifier	NCT04454697
Sponsor	University Hospital Heidelberg
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Diagnosis of a malignant head and neck tumor
	Clinical target volume of radiotherapy may include portions of at least one region: oral cavity; Upper jaw; Lower jaw; Oropharynx; Hypopharynx; large salivary glands
	Indication for radiotherapy alone (postoperative or definitive)
	Age 18 years
	Karnofsky performance score 60
	Completed wound healing after tumor resection
	The patient's consent and written consent
	Ability of the patient to assess the nature and scope as well as possible consequences of the clinical study
	Adequate contraception in women of childbearing potential and in men
Exclusion Criteria
	Pre-radiation in the head and neck area
	Multifocal, diffuse growing tumors
	Inadequate regression of toxicities from previous therapies
	Jaw clamp (cutting edge distance 2 cm)
	Simultaneous systemic tumor therapy during radiation (especially chemotherapy and immunotherapy)
	Indications that the participant is unlikely to adhere to the study protocol (e.g. lack of compliance)
	Missing written declaration of consent

How to participate?

Step 1 Connect with a study center

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

head and neck cancer

dental caries

neck tumor

head and neck neoplasms

tumour resection

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Tissue Retractors for Radiation Therapy of Head and Neck Tumors